News
![Biogen Hillerød, Denmark](https://pharmaphorum.com/wp-content/uploads/2020/11/Biogen-Hillerød-Denmark-.jpg)
Biogen waves bye to $217m ALS partnership with Karyopharm
Biogen has ducked out of a four-year-old collaboration with Karyopharm on a drug candidate for the neurodegenerative disease amyotrophic lateral sclerosis that could have been worth up to $